Background and objectives: Allogeneic stem cell transplantation (Allo-SCT) in elderly patients is a growing practice. We aimed to determine the graft-versus-host disease (GVHD) relapse-free survival (GRFS) in patients ≥65 years who underwent Allo-SCT in two countries from Latin America. Patients and methods: We performed a retrospective analysis of patients ≥65 years who underwent Allo-SCT in Argentina and Brazil from 2007 to 2019. Results: Ninety-eight patients were evaluated, with primary diagnoses of acute myeloid leukemia and myelodysplastic syndrome; 30% of patients had a hematopoietic cell transplant-comorbidity index (HCT-CI) score ≥3 and 49% were in complete remission. Donor types included matched sibling (n ¼ 41), matched unrelated (n ¼ 31), and haploidentical (HID; n ¼ 26) donors. The conditioning regimen was myeloablative in 28 patients (14 busulfan pharmacokinetically [PK]-guided) and reduced-intensity in 70 patients. The two-year non-relapse mortality (NRM) was 29%, with a higher NRM in melphalan-based compared to other conditionings (51% vs. 33%, p ¼ 0.02). The two-year relapse rate was 24%, with a reduction in PK-guided busulfan (0% vs. 28%, p ¼ 0.03). The two-year overall survival (OS) and GRFS was 52% and 38%, respectively, with a significant reduction in GRFS in HCT-CI ≥3 (27% vs. others 42%, p ¼ 0.02) and donors ≥40 years (29% vs.55%, p ¼ 0.02). These variables remained significantly associated with GRFS after multivariate analysis. Conclusion: In this cohort of elderly patients from Argentina and Brazil undergoing Allo-SCT, donor age and comorbidities significantly influenced GRFS. The role of the conditioning regimen in this population deserves further investigation.
Mariano, Berro; Hamerschlak, Nelson; Vera, Milovic; Belen, Castro; Andres, García P.; Gonzalo, Ferini; Jos, Real J.; Adriana, Vitriu; Alberto, Gimenez C.; Georgina, Bendek; Sebastian, Yantorno; Juliana, Martinez R.; Martin, Saslavsky; Sol, Jarchum; Amalia, Cerutti; Cinthya, Correa da S.; Morgani, Rodrigues; Leandro, Riera; Jorge, Arbelbide; Gustavo, Kusminsky; and Lisa, Basquiera A.
"Donor age influences graft-versus-host-disease-relapse-free survival after allogeneic stem cell transplant in elderly patients in two countries from Latin America,"
Hematology/Oncology and Stem Cell Therapy: Vol. 16
, Article 5.
Available at: https://doi.org/10.56875/2589-0646.1042
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.